Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
FDF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Anhydrous Dibasic Calcium Phosphate
2. Calcium Phosphate (cahpo4)
3. Calcium Phosphate, Dibasic, Anhydrous
4. Dibasic Calcium Phosphate, Anhydrous
5. Monetite
1. 7757-93-9
2. Calcium Phosphate Dibasic
3. Dicalcium Phosphate
4. Calcium Phosphate, Dibasic
5. Dibasic Calcium Phosphate
6. Phosphoric Acid, Calcium Salt (1:1)
7. Secondary Calcium Phosphate
8. Calcium Phosphate (1:1)
9. Dicalcium Orthophosphate
10. Calcium Hydrogen Orthophosphate
11. Monocalcium Acid Phosphate
12. Dicalcium Phosphate Anhydrous
13. Calcium Monohydrogen Phosphate
14. Calciumphosphate,dibasic
15. Calcium Phosphate Dibasic Anhydrous
16. Anhydrous Dibasic Calcium Phosphate
17. Calcium Phosphate,dibasic
18. Mfcd00010909
19. Calcium Phosphate (dibasic)
20. Chebi:32596
21. Ins-341(ii)
22. L11k75p92j
23. Calcium Phosphate, Dibasic, Anhydrous
24. E-341(ii)
25. Biofos
26. Fujicalin S
27. Dicafos An
28. 7557-93-9
29. Anhydrous Emcompress
30. Ipifosc 20
31. A-tab
32. D-glucopyranosiduronicacid, 1-(2,4-dichlorophenyl)ethyl
33. Calcium Acid Phosphate
34. Calcium Dibasic Phosphate
35. Calcium Secondary Phosphate
36. Calcium Phosphate (cahpo4)
37. Monohydrogen Calcium Phosphate
38. Ccris 1337
39. Hsdb 992
40. Cahpo4
41. Calcium Phosphate, Dibasic [jan]
42. Einecs 231-826-1
43. Calcium Hydrogenorthophosphate
44. Calcium Phosphate, Dibasic, Dental Grade
45. Unii-l11k75p92j
46. Calstar (tn)
47. Calcium Monohydrogen Phosphate Anhydrous
48. Calcii Hydrogenophosphas
49. Calcium;hydrogen Phosphate
50. Ec 231-826-1
51. Calcium Monohydrogenphosphate
52. Dicalcium Phosphate, Anhydrous
53. Calcium (as Phosphate,dibasic)
54. Ins No.341(ii)
55. Chembl2107567
56. Dtxsid20872529
57. Dicalcium Phosphate [inci]
58. Phosphoric Acid Calcium Salt
59. Calcium Hydrogen Monophosphate
60. Calcium Hydrogen Phosphate, Anhydrous
61. Akos015965054
62. Calcium Hydrogenorthophosphate Anhydrous
63. Calcium Phosphate, Dibasic [mi]
64. Calcium Phosphate,dibasic [vandf]
65. Calcium Hydrogenorthophosphate, With A Fluorine Content Of Less Than 0,005 Per Cent By Weight On The Dry Anhydrous Product
66. Calcium Phosphate, Dibasic [hsdb]
67. Dibasic Calcium Phosphate Anhydrous
68. Calcium Hydrogen Phosphate Anhydrous
69. Calcium Phosphate Dibasic [who-dd]
70. Calcium Phosphate, Dibasic (99.95%-ca)
71. Phosphorus (as Dicalcium Phosphate)
72. Calcium Phosphate (1:1) [who-ip]
73. Calcium Phosphate Dibasic, 98.0-105.0%
74. Calcium Phosphate, Dibasic Anhydrous
75. Dibasic Calcium Phosphate, Anhydrous (jan)
76. Calcium Phosphate Dibasic, Puriss., 98.0%
77. Ft-0623397
78. Calcium (calcium Phosphate (dibasic))
79. Calcium Hydrogen Phosphate (anhydrous)
80. Calcii Hydrogenophosphas [who-ip Latin]
81. Calcium (as Phosphate,dibasic) [vandf]
82. D03302
83. Anhydrous Dibasic Calcium Phosphate [jan]
84. Calcium Hydrogen Phosphate [ep Monograph]
85. Calcium Phosphate Dibasic Anhydrous, Usp Fcc Pe
86. Calcium Phosphate Dibasic, Usp, 98.0-103.0%
87. Calcium Phosphate, Dibasic, Anhydrous [ii]
88. Q414619
89. Phosphorus (as Dicalcium Phosphate) [vandf]
90. Calcium Hydrogen Phosphate, Anhydrous [who-ip]
91. Anhydrous Dibasic Calcium Phosphate [usp Monograph]
92. Dibasic Calcium Phosphate, Meets Usp Testing Specifications
93. Phosphorus (as Calcium Phosphate,dibasic) [vandf]
94. Calcium Phosphate Dibasic, Puriss. P.a., Anhydrous, >98.5% (kt)
Molecular Weight | 136.06 g/mol |
---|---|
Molecular Formula | CaHO4P |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 0 |
Exact Mass | 135.9238364 g/mol |
Monoisotopic Mass | 135.9238364 g/mol |
Topological Polar Surface Area | 83.4 Ų |
Heavy Atom Count | 6 |
Formal Charge | 0 |
Complexity | 46.5 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
USES--EXCELLENT SOURCE OF CALCIUM & PHOSPHORUS DURING PREGNANCY, LACTATION, OR MILD TO MODERATE HYPOCALCEMIA CHARACTERIZED BY LOW DEGREE OF TETANY. ... IF TETANY IS SEVERE, IV CALCIUM MEDICATION IS ADMIN. ... DOSE--1 TO 5 G/DAY IN 2 OR MORE DIVIDED DOSES.
Osol, A. and J.E. Hoover, et al. (eds.). Remington's Pharmaceutical Sciences. 15th ed. Easton, Pennsylvania: Mack Publishing Co., 1975., p. 770
IT IS NOT MARKETED IN SINGLE ENTITY FORM, SO THAT DOSE OF OTHER INGREDIENTS MAY HAVE TO BE CONSIDERED IN ARRIVING @ SUITABLE SCHEDULE. CALCIUM IS BETTER ABSORBED IF TAKEN IN SMALL DOSES @ FREQUENT INTERVALS.
Osol, A. and J.E. Hoover, et al. (eds.). Remington's Pharmaceutical Sciences. 15th ed. Easton, Pennsylvania: Mack Publishing Co., 1975., p. 770
MEDICATION (VET): FOR PREVENTION & TREATMENT OF RICKETS ALONG WITH VITAMIN D THERAPY, & AS NUTRIENT SOURCE OF CALCIUM & PHOSPHORUS IN FEEDSTUFFS. ... OPTIMUM CALCIUM:PHOSPHORUS RATIO IN DIET MUST ALSO BE MAINTAINED.
Rossoff, I.S. Handbook of Veterinary Drugs. New York: Springer Publishing Company, 1974., p. 71
DIBASIC CALCIUM PHOSPHATE, NATIONAL FORMULARY ... /IS AMONG CMPD/ CLASSIFIED AS NONSYSTEMIC GASTRIC ANTACIDS, BUT THEIR EFFICACY IS LOW & THEY ARE SELDOM EMPLOYED.
Goodman, L.S., and A. Gilman. (eds.) The Pharmacological Basis of Therapeutics. 5th ed. New York: Macmillan Publishing Co., Inc., 1975., p. 967
Medication (VET): Has been used as a dietary supplement, and as an antacid.
Budavari, S. (ed.). The Merck Index - Encyclopedia of Chemicals, Drugs and Biologicals. Rahway, NJ: Merck and Co., Inc., 1989., p. 256
BECAUSE OF PHOSPHATE CONTENT, IT IS CONTRAINDICATED IN /PERSONS WITH/ HYPOPARATHYROIDISM.
Osol, A. and J.E. Hoover, et al. (eds.). Remington's Pharmaceutical Sciences. 15th ed. Easton, Pennsylvania: Mack Publishing Co., 1975., p. 770
... ITS ELEMENTS ARE SLOWLY ABSORBED FROM SMALL INTESTINE.
Rossoff, I.S. Handbook of Veterinary Drugs. New York: Springer Publishing Company, 1974., p. 71
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
ABOUT THIS PAGE
A Calcium phosphate dibasic anhydrous manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Calcium phosphate dibasic anhydrous, including repackagers and relabelers. The FDA regulates Calcium phosphate dibasic anhydrous manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Calcium phosphate dibasic anhydrous API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Calcium phosphate dibasic anhydrous manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Calcium phosphate dibasic anhydrous supplier is an individual or a company that provides Calcium phosphate dibasic anhydrous active pharmaceutical ingredient (API) or Calcium phosphate dibasic anhydrous finished formulations upon request. The Calcium phosphate dibasic anhydrous suppliers may include Calcium phosphate dibasic anhydrous API manufacturers, exporters, distributors and traders.
click here to find a list of Calcium phosphate dibasic anhydrous suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Calcium phosphate dibasic anhydrous DMF (Drug Master File) is a document detailing the whole manufacturing process of Calcium phosphate dibasic anhydrous active pharmaceutical ingredient (API) in detail. Different forms of Calcium phosphate dibasic anhydrous DMFs exist exist since differing nations have different regulations, such as Calcium phosphate dibasic anhydrous USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Calcium phosphate dibasic anhydrous DMF submitted to regulatory agencies in the US is known as a USDMF. Calcium phosphate dibasic anhydrous USDMF includes data on Calcium phosphate dibasic anhydrous's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Calcium phosphate dibasic anhydrous USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Calcium phosphate dibasic anhydrous suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Calcium phosphate dibasic anhydrous as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Calcium phosphate dibasic anhydrous API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Calcium phosphate dibasic anhydrous as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Calcium phosphate dibasic anhydrous and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Calcium phosphate dibasic anhydrous NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Calcium phosphate dibasic anhydrous suppliers with NDC on PharmaCompass.
Calcium phosphate dibasic anhydrous Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Calcium phosphate dibasic anhydrous GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Calcium phosphate dibasic anhydrous GMP manufacturer or Calcium phosphate dibasic anhydrous GMP API supplier for your needs.
A Calcium phosphate dibasic anhydrous CoA (Certificate of Analysis) is a formal document that attests to Calcium phosphate dibasic anhydrous's compliance with Calcium phosphate dibasic anhydrous specifications and serves as a tool for batch-level quality control.
Calcium phosphate dibasic anhydrous CoA mostly includes findings from lab analyses of a specific batch. For each Calcium phosphate dibasic anhydrous CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Calcium phosphate dibasic anhydrous may be tested according to a variety of international standards, such as European Pharmacopoeia (Calcium phosphate dibasic anhydrous EP), Calcium phosphate dibasic anhydrous JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Calcium phosphate dibasic anhydrous USP).
LOOKING FOR A SUPPLIER?